Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial
Not Applicable
Completed
- Conditions
- Kidney Transplant
- Interventions
- Behavioral: TAKE IT Strategy
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 449
- Registration Number
- NCT03104868
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Mayo Clinic, Arizona, Scottsdale, Arizona, United States
Understanding Perspectives of Frequently-Admitted Hospital Patients
Not Applicable
Completed
- Conditions
- High Utilizers of Hospital CarePatient-Centered CareContinuity of Patient Care
- Interventions
- Other: CHAMP
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 151
- Registration Number
- NCT03097640
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
LiveWell: A Mobile Intervention for Bipolar Disorder
Not Applicable
Completed
- Conditions
- Bipolar DisorderBipolar I Disorder
- Interventions
- Other: Psychiatric managementBehavioral: Psychosocial treatmentBehavioral: LiveWell Program
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 205
- Registration Number
- NCT03088462
- Locations
- 🇺🇸
HealthPartners Institute, Bloomington, Minnesota, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 2
Active, not recruiting
- Conditions
- Lymphocyte-Rich Classical Hodgkin LymphomaRecurrent Lymphocyte-Depleted Classical Hodgkin LymphomaRecurrent Mixed Cellularity Classical Hodgkin LymphomaRecurrent Nodular Sclerosis Classical Hodgkin LymphomaRefractory Lymphocyte-Depleted Classical Hodgkin LymphomaRefractory Mixed Cellularity Classical Hodgkin LymphomaRefractory Nodular Sclerosis Classical Hodgkin Lymphoma
- Interventions
- Other: Laboratory Biomarker AnalysisBiological: Pembrolizumab
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 43
- Registration Number
- NCT03077828
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸Augusta University Medical Center, Augusta, Georgia, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
Reducing Tobacco Use Disparities Among Low-Income Adults
Not Applicable
Completed
- Conditions
- Nicotine DependenceCigarette Smoking
- Interventions
- Behavioral: Enhanced usual careBehavioral: Choose to Change
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 190
- Registration Number
- NCT03077737
- Locations
- 🇺🇸
Northwestern University Feingberg School of Medicine, Dept. of Preventive Medicine, Chicago, Illinois, United States
Use of Simulation to Improve VAD Self-management
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Other: Simulation-based Mastery Learning (SBML)
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 143
- Registration Number
- NCT03073005
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
Phase 1
Completed
- Conditions
- GliomaAnaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic OligoastrocytomaAstrocytoma, Grade IIIGlioblastoma MultiformeAstrocytoma, Grade IVBrain Cancer
- Interventions
- Biological: Neural stem cells loaded with an oncolytic adenovirus
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 12
- Registration Number
- NCT03072134
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸City of Hope, Duarte, California, United States
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Phase 2
Terminated
- Conditions
- Breast Carcinoma Metastatic in the BoneEstrogen Receptor PositiveCirculating Tumor Cell CountStage IV Breast CancerHER2/Neu NegativeProgesterone Receptor Positive
- Interventions
- Biological: DenosumabOther: Laboratory Biomarker Analysis
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 1
- Registration Number
- NCT03070002
- Locations
- 🇺🇸
Northwestern University- Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Evaluation of a Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization in Low Income Adults
Not Applicable
Completed
- Conditions
- Patient Readmission
- Interventions
- Other: Federally Qualified Health CenterOther: Northwestern Follow Up Care Coordination
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 654
- Registration Number
- NCT03066492
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
Photodynamic Therapy Incubation Times for Actinic Keratosis
Not Applicable
Active, not recruiting
- Conditions
- Actinic Keratoses
- Interventions
- Device: Blue light therapy
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 60
- Registration Number
- NCT03066843
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath